Literature DB >> 2896913

Contribution of gut bacterial metabolism to human metabolic disease.

M D Bain1, M Jones, S P Borriello, P J Reed, B M Tracey, R A Chalmers, T E Stacey.   

Abstract

Metronidazole, an antibiotic with specific activity against anaerobic bacteria, was of clinical and biochemical benefit in two patients with methylmalonic aciduria. The virtual elimination of propionic acid from the stool suggested that propionic acid derived from faecal bacterial metabolism contributes substantially to methylmalonate production. These findings point to a novel avenue of treatment for these disorders of intermediary metabolism, and indicate the importance of microbial gut flora in normal human metabolism.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2896913     DOI: 10.1016/s0140-6736(88)91898-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  18 in total

1.  The use of metronidazole in management of methylmalonic and propionic acidaemias.

Authors:  G N Thompson; R A Chalmers; J H Walter; J L Bresson; S L Lyonnet; P J Reed; J M Saudubray; J V Leonard; D Halliday
Journal:  Eur J Pediatr       Date:  1990-08       Impact factor: 3.183

Review 2.  Nutrition therapy of organic acidaemias with amino acid-based formulas: emphasis on methylmalonic and propionic acidaemia.

Authors:  Steven Yannicelli
Journal:  J Inherit Metab Dis       Date:  2006 Apr-Jun       Impact factor: 4.982

3.  Comparison of patients with complete and partial biotinidase deficiency: biochemical studies.

Authors:  T M Suormala; E R Baumgartner; H Wick; S Scheibenreiter; S Schweitzer
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

4.  Effect of oral antibiotics on intestinal production of propionic acid.

Authors:  A F Mellon; S A Deshpande; J C Mathers; K Bartlett
Journal:  Arch Dis Child       Date:  2000-02       Impact factor: 3.791

Review 5.  Current research in the organic acidurias.

Authors:  R A Chalmers
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

6.  Normal growth and development with unrestricted protein intake after severe infantile propionic acidaemia.

Authors:  A S Luder; S Yannicelli; C L Green
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

7.  Propionic acidaemia: clinical, biochemical and therapeutic aspects. Experience in 30 patients.

Authors:  W Lehnert; W Sperl; T Suormala; E R Baumgartner
Journal:  Eur J Pediatr       Date:  1994       Impact factor: 3.183

8.  Atypical vitamin B12-unresponsive methylmalonic aciduria in sibship with severe progressive encephalomyelopathy: a new genetic disease?

Authors:  E Mayatepek; G F Hoffmann; R Baumgartner; A Schulze; C Jakobs; F K Trefz; H J Bremer
Journal:  Eur J Pediatr       Date:  1996-05       Impact factor: 3.183

9.  Acylcarnitine profile in tissues and body fluids of biotin-deficient rats with and without L-carnitine supplementation.

Authors:  Y Shigematsu; I L Bykov; Y Y Liu; A Nakai; Y Kikawa; M Sudo; M Fujioka
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

10.  Use of human somatotrophin in the treatment of a patient with methylmalonic aciduria.

Authors:  M D Bain; S S Nussey; M Jones; R A Chalmers
Journal:  Eur J Pediatr       Date:  1995-10       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.